Japan Continuous Glucose Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Japan Continuous Glucose Monitoring Devices Market Report is Segmented by Individual Components Such As Sensors and Durables (receivers and Transmitters), and by Provinces. The Report Offers the Value (in USD) and Volume (in Units) for the Above Segments.

Japan Continuous Glucose Monitoring Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Japan Continuous Glucose Monitoring Devices Market Size

View Global Report
Japan Continuous Glucose Monitoring Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Market Size (2025) USD 106.68 Million
Market Size (2030) USD 179.69 Million
CAGR (2025 - 2030) 10.99 %
Market Concentration High

Major Players

Japan Continuous Glucose Monitoring Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Japan Continuous Glucose Monitoring Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Japan Continuous Glucose Monitoring Devices Market Analysis

The Japan Continuous Glucose Monitoring Devices Market size is estimated at USD 106.68 million in 2025, and is expected to reach USD 179.69 million by 2030, at a CAGR of 10.99% during the forecast period (2025-2030).

COVID-19 disrupted all aspects of the diabetes industry worldwide and in Japan. Several companies faced disruptions in supply and distribution channels nationwide since most of the CGM device components were manufactured outside of Japan. This created a gap between the supply and demand of the devices wherein the limited inventory was available. As a result, the impact of COVID-19 was considerable concerning access to a persistent continuum of care among the Japanese diabetic population. For instance, as per the primary insights, "Almost all Japanese diabetes patients visited their hospital or clinic every 2-3 months despite the COVID-19 pandemic. However, HCPs had limited communication with their patients, which impacted the consumer base and made it difficult to gain new users. In addition, the companies dealing in diabetes care were shut down, and patients visiting hospitals/clinics were unable to provide the product's information to HCPs" (Registered Nurse, Diabetes Care Japan, Lifescan).

Diabetes is a chronic condition marked by high blood glucose levels. It is caused either by the inability to produce insulin (a hormone made by the pancreas to keep blood glucose levels in range) or by the body not being able to use insulin effectively, or both.

Type 1 diabetic patients need to take insulin throughout their lives and maintain a healthy diet and regular physical exercise. Whereas Type 2 diabetic patients need to eat healthily, be physically active, and test their blood glucose level, and may also need to take oral medication and insulin to control the glucose level in their blood. The need for monitoring blood glucose levels is on the rise among diabetic patients, mainly to avoid complications, such as cardiovascular diseases, stroke, blood disorders, blindness, and kidney disorder, among others.

Various CGM devices are available in the japan market. Dexcom develops and manufactures the current-generation G6 CGM. Terumo markets the G6 in Japan. The Dexcom G6 system features a wearable sensor attached to a user's abdomen. It automatically transmits glucose measurements every five minutes to a monitor or smart device with a dedicated application. Users can check their real-time glucose values and trends through a visualized graph. Additionally, G6 notifies users when glucose measurements fall outside a pre-set target range. It also sends alerts upon predictions of hypoglycemia occurring in 20 minutes.

Japan Continuous Glucose Monitoring Devices Industry Overview

The Japanese continuous glucose monitoring devices market is highly consolidated. Market leaders such as Dexcom, Abbott, and Medtronic are focusing on product launches and technological collaboration to increase their foothold in the market.

Japan Continuous Glucose Monitoring Devices Market Leaders

  1. Dexcom

  2. Medtronic

  3. Abbott

  4. Everesense

  5. Ascensia

  6. *Disclaimer: Major Players sorted in no particular order
Japan Continuous Glucose Monitoring Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Japan Continuous Glucose Monitoring Devices Market News

  • October 2023: Terumo and Dexcom mutually agreed to conclude their domestic sales agency contract by the end of March 2024. Upon the termination of the distributor agreement, Terumo will no longer be responsible for the sales and support of Dexcom's CGM device in Japan. Dexcom will assume full responsibility for these operations within the country. Both Terumo and Dexcom are committed to ensuring a smooth transition and will continue to provide the same level of services and support to patients and healthcare professionals during the transition period, which will extend until the end of March 2024.
  • May 2023: Dexcom showcased the accuracy, reliability, and ease of use of its Dexcom G6 CGM System and highlighted the latest clinical evidence that demonstrates the effectiveness of Dexcom CGM during the 66th Annual Meeting of the Japan Diabetes Society held in Kagoshima, Japan.

Japan Continuous Glucose Monitoring DevicesMarket Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rapidly Increasing Incidence and Prevalence of Diabetes
    • 4.2.2 Technological Advancements in the Market
  • 4.3 Market Restraints
    • 4.3.1 Monopolized Supply Chain and High Cost of Devices
  • 4.4 Industry Attractiveness - Porter Five Forces
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry
  • 4.5 Analysis of CGM Device Distribution Channels
  • 4.6 Analysis of CGM Device Prescribers

5. MARKET SEGMENTATION

  • 5.1 By Component
    • 5.1.1 Sensors
    • 5.1.2 Durables (Receivers and Transmitters)
  • 5.2 By Provinces (Quantitative Analysis)
    • 5.2.1 Hokkaido
    • 5.2.2 Tohoku
    • 5.2.3 Kanto
    • 5.2.4 Chubu
    • 5.2.5 Kansai
    • 5.2.6 Other Provinces

6. MARKET INDICATORS

  • 6.1 Type-1 and Type -2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott Diabetes Care Inc.
    • 7.1.2 Dexcom Inc.
    • 7.1.3 Medtronic PLC
    • 7.1.4 Eversense
    • 7.1.5 Ascensia
  • *List Not Exhaustive
  • 7.2 Company Share Analysis

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Japan Continuous Glucose Monitoring Devices Industry Segmentation

Continuous glucose monitoring is used to automatically keep an eye on blood sugar levels during the day and at night. At any time, one can rapidly determine their blood sugar level. They can notice trends by looking at their glucose fluctuations over several hours or days. The Japan Continuous Glucose Monitoring Devices Market is Segmented by individual components such as sensors and durables (receivers and transmitters), and by Provinces. The report offers the value (in USD) and volume (in Units) for the above segments.

By Component Sensors
Durables (Receivers and Transmitters)
By Provinces (Quantitative Analysis) Hokkaido
Tohoku
Kanto
Chubu
Kansai
Other Provinces
Need A Different Region or Segment?
Customize Now

Japan Continuous Glucose Monitoring DevicesMarket Research FAQs

How big is the Japan Continuous Glucose Monitoring Devices Market?

The Japan Continuous Glucose Monitoring Devices Market size is expected to reach USD 106.68 million in 2025 and grow at a CAGR of 10.99% to reach USD 179.69 million by 2030.

What is the current Japan Continuous Glucose Monitoring Devices Market size?

In 2025, the Japan Continuous Glucose Monitoring Devices Market size is expected to reach USD 106.68 million.

Who are the key players in Japan Continuous Glucose Monitoring Devices Market?

Dexcom, Medtronic, Abbott, Everesense and Ascensia are the major companies operating in the Japan Continuous Glucose Monitoring Devices Market.

What years does this Japan Continuous Glucose Monitoring Devices Market cover, and what was the market size in 2024?

In 2024, the Japan Continuous Glucose Monitoring Devices Market size was estimated at USD 94.96 million. The report covers the Japan Continuous Glucose Monitoring Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Japan Continuous Glucose Monitoring Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Japan Continuous Glucose Monitoring DevicesIndustry Report

Statistics for the 2025 Japan Continuous Glucose Monitoring Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Japan Continuous Glucose Monitoring Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.